<div class="container">

<table style="width: 100%;"><tr>
<td>ssscv</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Sample Size for Scaled Average BE using coefficient of variation (CV)</h2>

<h3>Description</h3>

<p>It calculates sample size for the scaled average bioequivalence test on ratio using coefficient of variation (CV).
</p>


<h3>Usage</h3>

<pre><code class="language-R">ssscv(CV, DesignNo = 1, True.R = 1, Alpha = 0.1, Beta = 0.2, Region = "EU", nMax = 999999)
</code></pre>


<h3>Arguments</h3>

<table>
<tr style="vertical-align: top;">
<td><code>CV</code></td>
<td>
<p>Coefficient of Variation (%)</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>DesignNo</code></td>
<td>
<p>Crossover design number.  
</p>
<pre>  
 Design Number (treatment x sequence x period)
 1 2x2x2 : RT TR
 2 2x4x2 (Balaam Design) : TT RR RT TR 
 3 2x2x3 (Two-sequence Dual Design): TRR RTT 
 4 2x2x4 : TRRT RTTR
 5 2x4x4 : TTRR RRTT TRRT RTTR
 6 3x6x3 (William Design for 3 treatments) + carry-over effect 
         : RBA ARB BAR ABR BRA RAB
 7 3x6x3 (William Design for 3 treatments) - carry-over effect 
         : RBA ARB BAR ABR BRA RAB
 8 4x4x4 (William Design for 4 treatments) + carry-over effect 
         : RCAB ARBC BACR CBRA
 9 4x4x4 (William Design for 4 treatments) - carry-over effect 
         : RCAB ARBC BACR CBRA 
</pre>  
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>True.R</code></td>
<td>
<p>True ratio of test/reference</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>Alpha</code></td>
<td>
<p>Alpha error level</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>Beta</code></td>
<td>
<p>Beta error level</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>Region</code></td>
<td>
<p>US or FDA for US FDA, KR or MFDS for Korea MFDS, EU or EMA for other regions or countries</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>nMax</code></td>
<td>
<p>Maximum subject number (sample size) per group</p>
</td>
</tr>
</table>
<h3>Details</h3>

<p>It calculates sample size (n per group) with <code>CV</code>, <code>Alpha</code>, and <code>Beta</code> for scaled average bioequivalence test. US FDA uses this widened bound for both AUClast and Cmax, while EU EMA and Korea MFDA use this for Cmax only.
</p>


<h3>Value</h3>

<p>Returns sample size (n per group) for scaled average bioequivalence test with ratio criteria.
</p>


<h3>Author(s)</h3>

<p>Kyun-Seop Bae &lt;k@acr.kr&gt;</p>


<h3>Examples</h3>

<pre><code class="language-R">ssscv(42.2, DesignNo=4, True.R=0.9) # 14 per group, EU EMA. This applies only for Cmax
ssscv(42.2, DesignNo=4, True.R=0.9, Region="US") # 9 per group, US FDA
ssscv(42.2, DesignNo=4, True.R=0.9, Region="KR") # 14 per group, Korea MFDS. Only for Cmax
</code></pre>


</div>